FIXX News and Press, Homology Medicines Inc. From 04/06/22

Shares of Homology Medicines  [[FIXX, -11.11%]] fell on Wednesday after Canaccord Genuity cut its price target on the stock to $7 from $19, noting that the clinical hold on the company's pheNIX gene therapy trial of HMI-102 for phenylketonuria may be prolonged. In February, the gene...

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Homology Medicines, Inc. (“Homology” or the “Company”) (NASDAQ: FIXX) on behalf of Homology stockholders. Our investigation concern...

New York, New York--(Newsfile Corp. - March 30, 2022) - Levi & Korsinsky, LLP notifies investors in Homology Medicines, Inc. ("Homology" or the "Company") (NASDAQ: FIXX) of a class action securities lawsuit. The lawsuit on behalf of Homology investors has been commenced in the the Unite...

Homology Medicines press release (NASDAQ:FIXX): Q4 GAAP EPS of -$0.59 beats by $0.02. Revenue of $0.8M misses by $0.1M. For further details see: Homology Medicines GAAP EPS of -$0.59 beats by $0.02, revenue of $0.8M misses by $0.1M

- Formed New AAV Manufacturing and Innovation Business with Oxford Biomedica to Leverage Homology’s Process Development and Manufacturing Capabilities - - Received $130 Million Non-Dilutive Capital that Significantly Extends Cash Runway - - ...

BEDFORD, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the successful closing of the deal with Oxford Biomedica plc (LSE: OXB) to establish an Adeno-Associated Virus (AAV) Manufacturing and Innovation Business...

Gainers: IntriCon (NASDAQ:IIN) +37%. NeuroSense Therapeutics (NASDAQ:NRSN) +28%. Homology Medicines (NASDAQ:FIXX) +17%. CorMedix (NASDAQ:CRMD) +14%. Reata Pharmaceuticals (NASDAQ:RETA) +13%. Losers: Aurinia Pharmaceuticals (NASDAQ:AUPH) -29%. Lexicon Pharmac...

Renewable Energy REGI +38% Chevron to buy Renewable Energy Group in $3.15B deal. First Horizon (NYSE:FHN) +33% TD to expand in the southeastern U.S. with acquisition of First Horizon. NeuroSense Therapeutics (NASDAQ:NRSN) +27%. Indonesia Energy (NYSE:INDO) +19%. Alfi (NASDAQ:AL...

Gainers: Renewable Energy Group REGI +34%. Golden Entertainment (NASDAQ:GDEN) +17%. Homology Medicines (NASDAQ:FIXX) +7%. Cara Therapeutics CARA +5%. Arcimoto (NASDAQ:FUV) +5%. Losers: Fate Therapeutics (NASDAQ:FATE) -5%. CSP  (NASDAQ:CSPI) -3%. ImmunityBio  (NAS...

For the overall market, Tuesday's midday trading was dominated by continued concerns about Russia and Ukraine, which had the major averages sharply lower during the early afternoon. That said, some individual stocks managed to post notable gains, with Donald Trump, earnings and regulator deci...